Scoping review of digital pathology for neoadjuvant rectal cancer response

Aim: Neoadjuvant therapy for locally advanced rectal cancer (LARC) yields variable patient responses. Artificial intelligence (AI) and digital pathology offer a novel approach to preoperatively predict treatment outcomes using histomorphological features, potentially guiding organ-preserving strategies. This scoping review maps the current literature on AI-driven neoadjuvant response prediction in LARC to evaluate algorithmic performance and identify methodological gaps. Methods: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for scoping reviews (PRISMA-ScR) guidelines, a structured search of PubMed, Embase, and the Cochrane Library was conducted for studies published within the last 10 years. Studies applying AI algorithms to pretreatment whole-slide images (WSIs) to predict neoadjuvant response in LARC were included. Results: Eleven publications were included. Ten studies used retrospective cohorts only, whereas one study also included a prospective validation cohort of 100 patients. Algorithmic frameworks predominantly featured classical machine learning, using software extraction of predefined features, and deep learning for autonomous pixel analysis. Across heterogeneous endpoints and cohorts, standalone classical machine-learning models reported external validation area under the receiver operating characteristic curve (AUC) of 0.811-0.908 (prospective: 0.733), a hybrid microenvironment model reported external AUCs of 0.643-0.656 (prospective: 0.630), and standalone deep-learning models reported an external AUC of 0.723 (internal: 0.710-0.81). Critical limitations across the field include heterogeneous clinical target endpoints, inconsistent baseline staging, and a reliance on “black box” algorithms lacking true biological explainability. Conclusion: AI-driven digital pathology demonstrates strong potential for predicting neoadjuvant treatment response in LARC. However, safe clinical implementation will require standardized endpoints, multimodal integration, and prospective multi-centre validation of algorithms anchored in verifiable tumour biology.

Authors

Institutions

Publication Details

Journal
Artificial Intelligence Surgery
Published
2026-11-17
DOI
https://doi.org/10.20517/ais.2026.90
Primary Topic
AI in cancer detection
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Scoping review of digital pathology for neoadjuvant rectal cancer response

James Atlas, Karolina Vernmark, Isaac Tranter‐Entwistle, Jesse Fischer et al.
Artificial Intelligence Surgery
AI in cancer detection
article

Scoping review of digital pathology for neoadjuvant rectal cancer response

James Atlas, Karolina Vernmark, Isaac Tranter‐Entwistle, Jesse Fischer, William Allen, Matthew Drake, Timothy Eglinton, John Pearson, Arthur Morley-Bunker
article en

Abstract

Aim: Neoadjuvant therapy for locally advanced rectal cancer (LARC) yields variable patient responses. Artificial intelligence (AI) and digital pathology offer a novel approach to preoperatively predict treatment outcomes using histomorphological features, potentially guiding organ-preserving strategies. This scoping review maps the current literature on AI-driven neoadjuvant response prediction in LARC to evaluate algorithmic performance and identify methodological gaps. Methods: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for scoping reviews (PRISMA-ScR) guidelines, a structured search of PubMed, Embase, and the Cochrane Library was conducted for studies published within the last 10 years. Studies applying AI algorithms to pretreatment whole-slide images (WSIs) to predict neoadjuvant response in LARC were included. Results: Eleven publications were included. Ten studies used retrospective cohorts only, whereas one study also included a prospective validation cohort of 100 patients. Algorithmic frameworks predominantly featured classical machine learning, using software extraction of predefined features, and deep learning for autonomous pixel analysis. Across heterogeneous endpoints and cohorts, standalone classical machine-learning models reported external validation area under the receiver operating characteristic curve (AUC) of 0.811-0.908 (prospective: 0.733), a hybrid microenvironment model reported external AUCs of 0.643-0.656 (prospective: 0.630), and standalone deep-learning models reported an external AUC of 0.723 (internal: 0.710-0.81). Critical limitations across the field include heterogeneous clinical target endpoints, inconsistent baseline staging, and a reliance on “black box” algorithms lacking true biological explainability. Conclusion: AI-driven digital pathology demonstrates strong potential for predicting neoadjuvant treatment response in LARC. However, safe clinical implementation will require standardized endpoints, multimodal integration, and prospective multi-centre validation of algorithms anchored in verifiable tumour biology.

Artificial Intelligence SurgeryVol. 6(4)
Linköping University (SE), University of Auckland (NZ), University of Canterbury (NZ), Waikato Hospital (NZ), Christchurch Hospital (NZ), Canterbury Health Laboratories (NZ), Clinical Trials New Zealand (NZ), Linköping University Hospital (SE), University of Waikato (NZ), University of Otago (NZ)
Good health and well-being
AI in cancer detection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon